Ligand validation:6BPL

3PE: 1,2-Distearoyl-sn-glycerophosphoethanolamine

3PE is a Ligand Of Interest in 6BPL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6BPL_3PE_B_603	26%	83%	0.13	0.927	0.64	0.16	-	-	0	0	14%	13.73
6BPL_3PE_B_601	18%	15%	0.181	0.88	1.97	1.83	3	5	0	0	37%	0.3725
6BPL_3PE_B_602	11%	80%	0.166	0.822	0.71	0.15	-	-	0	0	20%	19.61
6BPL_3PE_A_601	9%	20%	0.253	0.843	1.84	1.56	4	4	0	0	43%	0.4314
6BPP_3PE_B_617	24%	1%	0.123	0.912	4.89	2.89	2	3	0	0	10%	9.8
5WEH_3PE_D_101	61%	49%	0.119	0.907	0.91	1.07	3	2	1	0	100%	1
6W90_3PE_A_201	44%	50%	0.144	0.883	0.97	0.95	4	3	2	0	94%	0.9412
4QN9_3PE_B_606	36%	37%	0.248	0.97	1.03	1.41	2	5	1	0	86%	0.8627
8PC4_3PE_A_403	35%	65%	0.243	0.957	0.54	0.81	-	1	4	0	86%	0.8627
8P90_3PE_B_605	32%	68%	0.253	0.954	0.52	0.71	-	2	3	0	86%	0.8627

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.